Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma XenograftsChantale Farah(UCLouvain), Bénédicte F. Jordan(UCLouvain)BiomedicinesMarch 19, 202210.3390/biomedicines10030717Cited by 7SaveCiteExport RISWatch citationsRelated PapersInterruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects|Nature Communications|2018|186Luciferase transduction and selection protocol for reliable in vivo bioluminescent measurements in cancer research|Heliyon|2024|2